|
Clinical Trials and Observations
Citations 91-100 of 2742 total displayed.
|
Past content
(since May 1998):
|
Outcomes and predictors of very stable INR control during chronic anticoagulation therapy
- Daniel M. Witt, Thomas Delate, Nathan P. Clark, Chad Martell, Thu Tran, Mark A. Crowther, David A. Garcia, Walter Ageno, and Elaine M. Hylek, on behalf of the Warfarin Associated Research Projects and other EnDeavors (WARPED) Consortium
Blood 2009; 114: 952-956.
[Abstract]
[Full text]
[PDF]
De novo deletion 17p13.1 chronic lymphocytic leukemia shows significant clinical heterogeneity: the M. D. Anderson and Mayo Clinic experience
- Constantine S. Tam, Tait D. Shanafelt, William G. Wierda, Lynne V. Abruzzo, Daniel L. Van Dyke, Susan O'Brien, Alessandra Ferrajoli, Susan A. Lerner, Alice Lynn, Neil E. Kay, and Michael J. Keating
Blood 2009; 114: 957-964.
[Abstract]
[Full text]
[PDF]
WT1 mutations in T-ALL
- Valeria Tosello, Marc R. Mansour, Kelly Barnes, Maddalena Paganin, Maria Luisa Sulis, Sarah Jenkinson, Christopher G. Allen, Rosemary E. Gale, David C. Linch, Teresa Palomero, Pedro Real, Vundavalli Murty, Xiaopan Yao, Susan M. Richards, Anthony Goldstone, Jacob Rowe, Giuseppe Basso, Peter H. Wiernik, Elisabeth Paietta, Rob Pieters, Martin Horstmann, Jules P. P. Meijerink, and Adolfo A. Ferrando
Blood 2009; 114: 1038-1045.
[Abstract]
[Full text]
[PDF]
High-resolution genomic profiling of childhood T-ALL reveals frequent copy-number alterations affecting the TGF-β and PI3K-AKT pathways and deletions at 6q15-16.1 as a genomic marker for unfavorable early treatment response
- Marc Remke, Stefan Pfister, Corinne Kox, Grischa Toedt, Natalia Becker, Axel Benner, Wiebke Werft, Stephen Breit, Shuangyou Liu, Felix Engel, Andrea Wittmann, Martin Zimmermann, Martin Stanulla, Martin Schrappe, Wolf-Dieter Ludwig, Claus R. Bartram, Bernhard Radlwimmer, Martina U. Muckenthaler, Peter Lichter, and Andreas E. Kulozik
Blood 2009; 114: 1053-1062.
[Abstract]
[Full text]
[PDF]
Microarray-based classifiers and prognosis models identify subgroups with distinct clinical outcomes and high risk of AML transformation of myelodysplastic syndrome
- Ken I. Mills, Alexander Kohlmann, P. Mickey Williams, Lothar Wieczorek, Wei-min Liu, Rachel Li, Wen Wei, David T. Bowen, Helmut Loeffler, Jesus M. Hernandez, Wolf-Karsten Hofmann, and Torsten Haferlach
Blood 2009; 114: 1063-1072.
[Abstract]
[Full text]
[PDF]
TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors
- Holbrook E. Kohrt, Brit B. Turnbull, Kartoosh Heydari, Judith A. Shizuru, Ginna G. Laport, David B. Miklos, Laura J. Johnston, Sally Arai, Wen-Kai Weng, Richard T. Hoppe, Philip W. Lavori, Karl G. Blume, Robert S. Negrin, Samuel Strober, and Robert Lowsky
Blood 2009; 114: 1099-1109.
[Abstract]
[Full text]
[PDF]
Perspectives on thrombosis in essential thrombocythemia and polycythemia vera: is leukocytosis a causative factor?
- Tiziano Barbui, Alessandra Carobbio, Alessandro Rambaldi, and Guido Finazzi
Blood 2009; 114: 759-763.
[Abstract]
[Full text]
[PDF]
Safety and efficacy of single-agent lenalidomide in patients with relapsed and refractory multiple myeloma
- Paul Richardson, Sundar Jagannath, Mohamad Hussein, James Berenson, Seema Singhal, David Irwin, Stephanie F. Williams, William Bensinger, Ashraf Z. Badros, Robert Vescio, Laurie Kenvin, Zhinuan Yu, Marta Olesnyckyj, Jerome Zeldis, Robert Knight, and Kenneth C. Anderson
Blood 2009; 114: 772-778.
[Abstract]
[Full text]
[PDF]
Comparison of the rates of joint arthroplasty in patients with severe factor VIII and IX deficiency: an index of different clinical severity of the 2 coagulation disorders
- Giuseppe Tagariello, Alfonso Iorio, Elena Santagostino, Massimo Morfini, Ruggero Bisson, Massimo Innocenti, Maria Elisa Mancuso, Maria Gabriella Mazzucconi, Gian Luigi Pasta, Paolo Radossi, Giuseppina Rodorigo, Cristina Santoro, Roberto Sartori, Antonio Scaraggi, Luigi Pier Solimeno, and Pier Mannuccio Mannucci, on behalf of the Italian Association Hemophilia Centre (AICE)
Blood 2009; 114: 779-784.
[Abstract]
[Full text]
[PDF]
Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance
- Celine M. Vachon, Robert A. Kyle, Terry M. Therneau, Barbara J. Foreman, Dirk R. Larson, Colin L. Colby, Tara K. Phelps, Angela Dispenzieri, Shaji K. Kumar, Jerry A. Katzmann, and S. Vincent Rajkumar
Blood 2009; 114: 785-790.
[Abstract]
[Full text]
[PDF]
|
|
